← Insider buys
KALV

KalVista Pharmaceuticals, Inc. · Healthcare

Pres, CFO, CBO, Sec'y Benjamin L Palleiko sold $140K of KalVista Pharmaceuticals, Inc.

Sold$140,192
$10.73Price
13,067Shares
−12%Stake

What KALV did after the filing

Filed Aug 21Copier in Aug 22
The stock from Tue, Aug 22 open, $10.97
−17.6%
S&P 500, same days
−3.4%

Measured over 30 trading days, to the Oct 4 close.

Traded Fri, Aug 18. Filed Mon, Aug 21, 8:05 PM ET, after the close. Returns use the Aug 22 open and the Oct 4 close. Not investment advice.